VELEXIA-80 Tablets provide an established, clinically unified monotherapy carefully developed for the continuous management, long-term stabilization, and physiological protection of patients tracking essential Hypertension, heart failure loops, or post-myocardial infarction recovery phases. When the body’s renin-angiotensin-aldosterone system (RAAS) becomes chronically overactive, excessive secretion of angiotensin II forces systemic blood vessels into tight, sustained constriction. This narrow pathway spikes baseline blood pressure metrics, accelerates arterial structural damage, and forces the heart muscle to pump against dangerously high resistance. This advanced formulation delivers a selective, targeted receptor blocker within a standardized 80 mg unit to establish a highly balanced, smooth hemodynamic state safely over an extended care routine.
The active component, Valsartan (80 mg), functions dynamically via highly targeted cellular tracks:
-
Selective AT1 Receptor Blockade: It operates as an extremely potent, orally active antagonist at the angiotensin II type 1 ($AT_1$) receptor subtype. By selectively binding to these target nodes, it blocks the powerful vasoconstricting, aldosterone-secreting, and hypertrophic effects of angiotensin II without interfering with bradykinin pathways or triggering a dry cough response.
-
Systemic Vasodilation & Cardiac Unloading: By keeping smooth muscle walls relaxed, it systematically lowers total peripheral resistance (TPR). This drop in systemic pressure metrics directly unloads the left ventricle, reducing myocardial oxygen demand, preventing dangerous vascular remodeling loops, and protecting key target filters within the kidneys, brain, and heart around the clock.
Key Benefits
-
Targeted Vascular Relaxation: Blocks vasoconstriction signaling directly at the receptor level to smoothly lower systolic and diastolic baselines.
-
Robust Target Organ Shield: Lowers high-pressure mechanical friction across delicate arterial walls, protecting the brain, kidneys, and retina from structural damage.
-
Excellent Gastro & Tolerability Profile: Avoids the breakdown of bradykinin loops, making it an ideal choice for patients who track chronic dry cough lines with traditional ACE inhibitors.
-
Multi-Stage Cardiac Defense: Validated for high-performance safety across heart failure routines and secondary post-heart-attack stabilization phases.
-
Trusted Quality Execution: Manufactured under strict pharmaceutical protocols of DH, ensuring exceptional dissolution uniformity and steady structural bioavailability.
Directions for Use
-
Take exactly as directed by your cardiologist, nephrologist, or primary physician.
-
VELEXIA-80 can comfortably be taken either with or without food. Try to administer your dose at the exact same time every single morning to build a perfectly flat 24-hour plasma tracking baseline.
-
Swallow the tablet whole with a full glass of plain water. Do not crush, split, or chew it.
-
Maintain complete daily consistency; missing doses can cause systemic vascular resistance and pressure metrics to shift back rapidly behind tracking boundaries.
Safety & Precautions
-
Do not halt usage or adjust your dose suddenly without professional medical instruction, as blood pressure can rebound sharply.
-
Contraindicated in Pregnancy: Do not use this product if you are pregnant, planning a pregnancy, or nursing. Medicines acting directly on the renin-angiotensin system can cause severe harm, developmental tracking anomalies, or fetal death if used during the second and third trimesters.
-
Monitor your blood pressure, renal function panels (serum creatinine / eGFR), and serum potassium levels regularly, as ARB regimens require routine clinical tracking to preserve safe metabolic baselines.
-
Inform your specialist before initialization if you have an underlying history of bilateral renal artery stenosis, severe liver vulnerabilities (biliary cirrhosis), advanced dehydration, or generalized electrolyte imbalances.
-
Avoid sudden, rapid positional movements (like jumping up quickly from a bed layout) during the initial few days of therapy to prevent temporary mild dizziness.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and ambient environmental room moisture pools.
-
Always keep the tablets safely sealed inside their original protective blister packaging layout up until the second of intake to shield the core from ambient room humidity.
